Ursula von der Leyen Faces No-Confidence Vote over Pfizer Text Controversy

Ursula von der Leyen addresses a press conference at the end of the European Council Summit at the EU headquarters in Brussels on 28 June 2024.
John Thys/AFP
The European Parliament will debate and vote next week on a no-confidence motion against European Commission President Ursula von der Leyen, triggered by criticism over undisclosed vaccine-related messages with Pfizer’s CEO during the COVID-19 pandemic.

The European Parliament is set to debate a no-confidence motion against European Commission President Ursula von der Leyen on Monday, with a vote expected on Thursday, according to Belgian public broadcaster RTBF.

The motion, initiated by Romanian MEP Gheorghe Piperea of the nationalist Alliance for the Union of Romanians (AUR), part of the European Conservatives and Reformists (ECR) group, criticizes von der Leyen for a lack of transparency regarding text message exchanges with Pfizer CEO Albert Bourla during the COVID-19 pandemic. These messages reportedly related to the procurement of vaccines have never been made public.

EU Court Rules Against Von der Leyen in Historic Pfizergate Verdict

European Parliament President Roberta Metsola confirmed that the motion had gathered the required 72 signatures, meeting all procedural requirements for discussion and voting in a plenary session. For the motion to pass, it would need a two-thirds majority of votes cast and the support of an absolute majority of MEPs—at least 361 members.

If successful, the vote would force not only von der Leyen but the entire European Commission to resign.

The New York Times Sues EU Commission Over the Release of Pfizer Texts

Such an outcome would be unprecedented in recent EU history, with the only comparable case occurring in 1999, when the Santer Commission stepped down amid a damaging report on financial mismanagement and fraud.

The controversy intensified after the EU’s Court of Justice ruled in mid-May that the European Commission had failed to provide a satisfactory justification for withholding the vaccine-related texts. The court emphasized that, under EU law, all official documents must be accessible to the public.

The upcoming vote marks a critical moment for von der Leyen’s leadership just as the EU navigates a complex geopolitical and economic landscape ahead of the next Commission term.


Related articles:

Von der Leyen’s Week Marred by Private Jet Scandal, Pfizergate Ruling
Omnipresent von der Leyen’s Perpetual Campaign
The European Parliament will debate and vote next week on a no-confidence motion against European Commission President Ursula von der Leyen, triggered by criticism over undisclosed vaccine-related messages with Pfizer’s CEO during the COVID-19 pandemic.

CITATION